Detalhe da pesquisa
1.
Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics.
Biochem Biophys Res Commun
; 612: 181-187, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550505
2.
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.
Nature
; 514(7523): 455-61, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25296255
3.
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
PLoS Pathog
; 13(9): e1006641, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945784
4.
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
PLoS Pathog
; 12(7): e1005742, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27434311
5.
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
J Biol Chem
; 289(43): 29912-26, 2014 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25160627
6.
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.
PLoS Pathog
; 9(10): e1003738, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24204277
7.
UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C.
J Virol
; 86(9): 4989-99, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22379083
8.
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.
J Virol
; 85(10): 4828-40, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21389135
9.
Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.
J Virol
; 85(7): 3128-41, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21270156
10.
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals.
J Virol
; 85(21): 11502-19, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849452
11.
Immunization with HIV-1 trimeric SOSIP.664 BG505 or founder virus C (FVCEnv) covalently complexed to two-domain CD4S60C elicits cross-clade neutralizing antibodies in New Zealand white rabbits.
Vaccine X
; 12: 100222, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36262212
12.
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.
Sci Immunol
; 2(7)2017 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783671
13.
Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.
EBioMedicine
; 12: 196-207, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612593
14.
Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.
Cell Host Microbe
; 18(3): 354-62, 2015 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355218
15.
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.
Nat Med
; 18(11): 1688-92, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23086475
16.
Comparative analysis of expression and secretion of placental leptin in mammals.
Am J Physiol Regul Integr Comp Physiol
; 285(2): R438-46, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12702488